TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27127006

Group type: EXPERIMENTAL
Intervention: Avastin (bevacizumab) in combination with Temozolomide (TMZ) and Radiotherapy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Conventional MR imaging plus diffusion/perfusion imaging
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging
Number of subjects: 121
Study: 24942094

Group type: EXPERIMENTAL
Intervention: Piezoelectric ultrasonic bone surgery system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional bone chisels method
Number of subjects: 60
Study: 23647914

Group type: EXPERIMENTAL
Intervention: Whole body vibration training (3 sessions per week, 5 series of 15 seconds at 30 Hz frequency)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (normal daily life)
Number of subjects: 62
Study: 20089253

Group type: EXPERIMENTAL
Intervention: Integrated chronic care program (ICCP)
Number of subjects: 698
Study: 18470902

Group type: EXPERIMENTAL
Intervention: Cladribine alone
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Cladribine and cyclophosphamide combination
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cyclophosphamide, vincristine, and prednisone combination
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Cladribine-containing regimens (both cladribine alone and cladribine and cyclophosphamide combination)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Cladribine alone and cladribine and cyclophosphamide combination
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cladribine alone, cladribine and cyclophosphamide combination, and cyclophosphamide, vincristine, and prednisone combination
Number of subjects: 197
Study: 16919803

Group type: EXPERIMENTAL
Intervention: Computer-delivered HIV/AIDS risk reduction intervention
Number of subjects: 157

Group type: COMPARATOR
Intervention: Nutrition education tutorial (Control)
Number of subjects: 157
Study: 14510798

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Toremifene
Number of subjects: 60
Study: 11012559

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg at 40 degrees C
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo at 40 degrees C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg at 22 degrees C
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo at 22 degrees C
Number of subjects: 12
Study: 8960444

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitrates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Class I antiarrhythmic agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Magnesium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium antagonists
Number of subjects: 0
Study: 1577361

Group type: EXPERIMENTAL
Intervention: 10 mg haloperidol/day for 14 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 20 mg haloperidol/day for 14 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Individually matched haloperidol dosage for 14 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fixed doses (10 mg and 20 mg haloperidol)
Number of subjects: 90
Study: 3883868

Group type: EXPERIMENTAL
Intervention: Full-dose total lymphoid irradiation (2000 rad)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-dose total lymphoid irradiation (200 rad)
Number of subjects: 26
Study: 31108842

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 8 weeks, combined with standard swimming training (8 times a week)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard Swimming Training (ST) for 8 weeks, without additional IMT
Number of subjects: 16
Study: 28782541

Group type: EXPERIMENTAL
Intervention: Web-based transfer training module
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: In-person transfer training session
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waitlist control group (WLCG)
Number of subjects: 71
Study: 26402923

Group type: EXPERIMENTAL
Intervention: 0.5 mg testosterone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24363302

Group type: EXPERIMENTAL
Intervention: Sodium nitrite 40 mg
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Sodium nitrite 80 mg
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 22367259

Group type: EXPERIMENTAL
Intervention: Culturally tailored physical activity program
Number of subjects: 0
Study: 20487122

Group type: EXPERIMENTAL
Intervention: RVOT pacing
Number of subjects: 58

Group type: COMPARATOR
Intervention: RVA pacing
Number of subjects: 58
Study: 19009805

Group type: EXPERIMENTAL
Intervention: Mild hypothermia applied to the head or entire body, maintaining a temperature of 33-34 degrees C for 72 hours, started within 6 hours after birth.
Number of subjects: 200
Study: 16208798

Group type: EXPERIMENTAL
Intervention: Oral‐B ProfessionalCare 7000 (PC 7000)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Oral‐B 3D Excel (3DE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sonicare Advance (SA)
Number of subjects: 79
Study: 12504934

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 300 microg of Rhophylac
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of 300 microg of Rhophylac
Number of subjects: 14
Study: 10900538

Group type: EXPERIMENTAL
Intervention: Paracetamol generic products (500 mg tablets)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tylenol (reference product)
Number of subjects: 12
Study: 8858742

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 1516462

Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 10 mg/kg b.i.d.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 20 mg/kg b.i.d.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cefaclor 10 mg/kg t.i.d.
Number of subjects: 30
Study: 6373153

Group type: EXPERIMENTAL
Intervention: Microcrystalline hydroxyapatite compound (MCHC) 6 to 8 g for 12 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 40
Study: 30974188

Group type: EXPERIMENTAL
Intervention: HCO-CVVHD
Number of subjects: 35
Study: 28366816

Group type: EXPERIMENTAL
Intervention: Bright light exposure (1200lx) at varying room temperatures (26, 29, 32°C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dim light exposure (5lx) at varying room temperatures (26, 29, 32°C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower room temperature (26, 29, 32°C)
Number of subjects: 0
Study: 27170563

Group type: EXPERIMENTAL
Intervention: Dietary intervention (one face-to-face dietitian consultation, followed by phone reviews)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (BOS database)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Dietary intervention group
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 217
Study: 24727160

Group type: EXPERIMENTAL
Intervention: Once-weekly 56.5 μg teriparatide for 72 weeks
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 22621829

Group type: EXPERIMENTAL
Intervention: hCG-primed (10,000 IU)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Non-primed
Number of subjects: 82
Study: 21058604

Group type: EXPERIMENTAL
Intervention: Self-talk intervention (self-determined instructional cue words)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no self-talk intervention)
Number of subjects: 16
Study: 17402960

Group type: EXPERIMENTAL
Intervention: Reflexology for 30 minutes
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group resting for 30 minutes
Number of subjects: 9
Study: 16336019

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 301

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 301
Study: 11677105

Group type: EXPERIMENTAL
Intervention: One course of perioperative polychemotherapy (anthracycline-containing regimen within 36 hours after surgery)
Number of subjects: 2795

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 2795
Study: 9625243

Group type: EXPERIMENTAL
Intervention: Honey dressing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Silver sulfadiazine (SSD)
Number of subjects: 50
Study: 7606631

Group type: EXPERIMENTAL
Intervention: Submaximal exercise test for 30 min at 60% of individual maximal work capacity
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resting condition
Number of subjects: 16
Study: 3554627

Group type: EXPERIMENTAL
Intervention: Activated charcoal suspension (105 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sorbitol-charcoal suspension (105 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Phenobarbital i.v. alone
Number of subjects: 6
Study: 30625492

Group type: EXPERIMENTAL
Intervention: Left thalamic stimulation
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Right thalamic stimulation
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Bilateral thalamic stimulation (Bil-ON)
Number of subjects: 7

Group type: COMPARATOR
Intervention: No stimulation (Bil-OFF)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Unilateral nondominant stimulation
Number of subjects: 7
Study: 28025642

Group type: EXPERIMENTAL
Intervention: Short duration small sided football (FG15)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Long duration small sided football (FG60)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low magnitude whole body vibration (VIB)
Number of subjects: 56
Study: 24911260

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy (ICBT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 90
Study: 23910201

Group type: EXPERIMENTAL
Intervention: Loaded miniscrew implants
Number of subjects: 36

Group type: COMPARATOR
Intervention: Unloaded miniscrew implants
Number of subjects: 36
Study: 21208128

Group type: EXPERIMENTAL
Intervention: Bed of nails (BN)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Relaxing instructions and music
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Relaxing instructions
Number of subjects: 32
Study: 17933452

Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Transcutaneous pacing (TCP)
Number of subjects: 151
Study: 16502744

Group type: EXPERIMENTAL
Intervention: TENS group (electrical stimulation of the wrist and finger extensors for 1 h/day in addition to neurodevelopmental exercises)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (neurodevelopmental exercises only for 1 h/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Both groups (TENS and control)
Number of subjects: 36
Study: 14505201

Group type: EXPERIMENTAL
Intervention: Ruby laser treatment (3 treatments given at monthly intervals)
Number of subjects: 69
Study: 10872958

Group type: EXPERIMENTAL
Intervention: Doxycycline treatment (8.5% sustained-release biodegradable gel)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral hygiene instruction/reinforcement (Control)
Number of subjects: 45
Study: 9331117

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 plus carboplatin (AUC 6)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Paclitaxel 225 mg/m2 plus carboplatin (AUC 6)
Number of subjects: 49
Study: 7963760

Group type: EXPERIMENTAL
Intervention: Localized radiation treatment (1.8 Gy per fraction, 17 fractions)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Localized radiation treatment
Number of subjects: 15
Study: 6620012

Group type: EXPERIMENTAL
Intervention: Prone, head-elevated positioning in a harness
Number of subjects: 15

Group type: COMPARATOR
Intervention: Infant seat
Number of subjects: 15
Study: 30449208

Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated equine estrogen (CEE) and 100 mg of micronized progesterone (MP)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 0.3 mg of CEE and 100 mg of MP
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 0.625 mg of CEE and 10 mg of dydrogesterone (DDG)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 123
Study: 30056419

Group type: EXPERIMENTAL
Intervention: Coconut oil enriched Mediterranean diet for 21 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 26765495

Group type: EXPERIMENTAL
Intervention: Sports bras (six randomly assigned breast support levels)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Perceptual questionnaire (bra comfort, bra fit, breast pain)
Number of subjects: 17
Study: 25123116

Group type: EXPERIMENTAL
Intervention: BCG and HA (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: BCG only (Group A)
Number of subjects: 30
Study: 23634562

Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous nerve stimulation) preincisionally and postoperatively
Number of subjects: 35

Group type: COMPARATOR
Intervention: Piritramide intravenously (i.v.) by patient-controlled analgesia pump
Number of subjects: 35
Study: 19430254

Group type: EXPERIMENTAL
Intervention: IMPACT program
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 269
Study: 18051206

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azelastine plus nasal corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16512751

Group type: EXPERIMENTAL
Intervention: 0.2% alcohol-free chlorhexidine mouthrinse used twice per day for 1 week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo mouthrinse used twice per day for 1 week
Number of subjects: 0
Study: 15464329

Group type: EXPERIMENTAL
Intervention: Silzone‐coated prosthetic valve
Number of subjects: 575

Group type: COMPARATOR
Intervention: Conventional prosthetic valve
Number of subjects: 575
Study: 11214093

Group type: EXPERIMENTAL
Intervention: Classical regimen (CQ for 3 days, followed by primaquine for 14 days)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Short regimen (CQ and primaquine given simultaneously for 5 days)
Number of subjects: 79
Study: 8984313

Group type: EXPERIMENTAL
Intervention: Optimized compression technique with a novel compression device, pressure of 40 to 45 mmHg, duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual compression and conventional pressure dressing, duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early ultrasound-guided compression therapy for pseudoaneurysms, duration not specified.
Number of subjects: 0
Study: 1856917

Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anesthetics (25 mg lidocaine and 25 mg prilocaine per gm)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 6349654

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (300 mg per day for one week)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Oxyphenbutazone (600 mg per day)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 31471234

Group type: EXPERIMENTAL
Intervention: max-pre-SD
Number of subjects: 309

Group type: COMPARATOR
Intervention: post-SD
Number of subjects: 309
Study: 31711451

Group type: EXPERIMENTAL
Intervention: ROP1.3 group (1.3 mL/kg of 0.15% ropivacaine)
Number of subjects: 96

Group type: COMPARATOR
Intervention: ROP1.0 group (1.0 mL/kg of 0.15% ropivacaine)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Non-caudal block group
Number of subjects: 96
Study: 28957818

Group type: EXPERIMENTAL
Intervention: 8 mg epilutein and 2 mg lutein (group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 mg lutein (group 2)
Number of subjects: 40
Study: 24133005

Group type: EXPERIMENTAL
Intervention: OTG3% 84 mg/day
Number of subjects: 626

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 626
Study: 25226730

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Mono-polar diathermy (electro-cautery)
Number of subjects: 92
Study: 21668987

Group type: EXPERIMENTAL
Intervention: Emergency department patient throughput times
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Patient inflow patterns
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diurnal variation in throughput times
Number of subjects: 6
Study: 18645727

Group type: EXPERIMENTAL
Intervention: Inhaled furosemide (4 ml equal to 40 mg in 10 min)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (4 ml of 0.9% saline solution)
Number of subjects: 41
Study: 16842467

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg, rifabutin 150 mg and amoxicillin 1 g, each given b.d. for 7 days (ERA)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Omeprazole 40 mg and amoxicillin 1000 mg, each given t.d.s. for 14 days (OA)
Number of subjects: 145
Study: 12802757

Group type: EXPERIMENTAL
Intervention: IFN-alpha-2a 6 MU 3 times per week for 24 weeks, then 3 MU 3 times per week for 24 weeks (group A)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: IFN-alpha-2a 9 MU per day for 2 weeks, then 3 MU per day for 22 weeks, then 3 MU 3 times per week for 24 weeks (group B)
Number of subjects: 68
Study: 10858178

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 295
Study: 8682978

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: History of conduct disorder
Number of subjects: 103

Group type: COMPARATOR
Intervention: No history of conduct disorder
Number of subjects: 103
Study: 1641524

Group type: EXPERIMENTAL
Intervention: Oestriol 3 mg p.o. per day for 4 weeks, followed by 1 mg per day for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6361789

Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Suprofen 400 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg plus codeine 60 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 31900167

Group type: EXPERIMENTAL
Intervention: Peer coaching intervention for the WHO Safe Childbirth Checklist
Number of subjects: 570
Study: 30763195

Group type: EXPERIMENTAL
Intervention: Decolonization (chlorhexidine mouthwash, baths or showers with chlorhexidine, and nasal mupirocin for 5 days twice per month for 6 months)
Number of subjects: 2121

Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 2121

Group type: EXPERIMENTAL
Intervention: Decolonization
Number of subjects: 2121

Group type: EXPERIMENTAL
Intervention: Decolonization (adhering fully to regimen)
Number of subjects: 2121
Study: 28933607

Group type: EXPERIMENTAL
Intervention: Mitii™ (20 weeks of training)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Care As Usual (waitlist control; n=30)
Number of subjects: 60
Study: 27184521

Group type: EXPERIMENTAL
Intervention: Antipsychotic review + social interaction
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Antipsychotic review + exercise
Number of subjects: 273

Group type: COMPARATOR
Intervention: Antipsychotic review alone
Number of subjects: 273
Study: 24840143

Group type: EXPERIMENTAL
Intervention: Experimental group (EG) received weekly patient progress feedback (OQ-45) and clinical support tools (CST) starting at t2.
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group (CG) received treatment-as-usual without additional feedback or tools.
Number of subjects: 252
Study: 22547605

Group type: EXPERIMENTAL
Intervention: Erlotinib alone (arm A)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Erlotinib plus carboplatin and paclitaxel (ECP) (arm B)
Number of subjects: 181
Study: 19397816

Group type: EXPERIMENTAL
Intervention: Recruitment methods (media techniques, direct contact, health care provider contacts)
Number of subjects: 58
Study: 17462986

Group type: EXPERIMENTAL
Intervention: Maternal and child health and family planning program initiated in Matlab in 1977
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison area (no specific intervention mentioned)
Number of subjects: 0
Study: 15986722

Group type: EXPERIMENTAL
Intervention: Neurorehabilitation
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: Early rehabilitation 'B'
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: GOS scores
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: Duration of rehabilitation
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: GCS and GOS assessment
Number of subjects: 6783
Study: 11476474

Group type: EXPERIMENTAL
Intervention: Allergen-specific immunotherapy (SIT)
Number of subjects: 0
Study: 9415087

Group type: EXPERIMENTAL
Intervention: Computer-assisted learning (CAL) programs in addition to daily formal teaching
Number of subjects: 26

Group type: COMPARATOR
Intervention: Daily formal teaching only (Control)
Number of subjects: 26
Study: 7937658

Group type: EXPERIMENTAL
Intervention: Breathing Exercises (BE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Yoga (Y)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 36
Study: 3107721

Group type: EXPERIMENTAL
Intervention: Gestrinone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: No visible endometriosis
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Residual endometriosis
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (unexplained infertility)
Number of subjects: 37
Study: 31758326

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: HPR Plus™
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 29696919

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-frequency electrical therapy combined with rehabilitation training
Number of subjects: 60
Study: 25988390

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SIJ injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided SIJ injection
Number of subjects: 40